Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers01:19

Blood Studies for Cardiovascular System II: CRP, Hcy, and Cardiac Natriuretic Peptide Markers

Cardiac biomarkers are critical in diagnosing, prognosing, and managing cardiovascular diseases. Routine measurement of specific biomarkers such as B-type natriuretic peptide (BNP), C-reactive protein (CRP), and homocysteine (Hcy) is common practice in clinical settings to evaluate heart function and predict cardiovascular events.
These markers indicate stress or strain on the heart muscle:
Natriuretic Peptides (BNP)
Cardiac myocytes produce these hormones in response to ventricular stretching...
Blood Studies for Cardiovascular System I: Cardiac Biomarkers01:20

Blood Studies for Cardiovascular System I: Cardiac Biomarkers

Cardiac biomarkers are enzymes, proteins, and hormones released into the blood when cardiac cells are injured. They are powerful tools for triaging.
The essential diagnostic tools for detecting myocardial necrosis and monitoring individuals suspected of having acute coronary syndrome (ACS) include:
Troponins
Troponins, particularly cardiac troponins I and T, are the most precise and sensitive markers of myocardial injury. They are detectable within 4-6 hours of myocardial injury and remain...
Myocarditis I: Introduction01:21

Myocarditis I: Introduction

Myocarditis is inflammation of the myocardium, which is the muscular layer of the heart.EtiologyMyocarditis has a diverse etiology, including a wide range of infectious and non-infectious causes:Infectious CausesViral: Common viruses include Coxsackie A and B, adenovirus, parvovirus B19, enteroviruses, and influenza A.Bacterial: Examples include infections caused by Streptococcus, Staphylococcus, and Mycoplasma species.Rickettsial: Infections like Rocky Mountain spotted fever can result in...
Acute Coronary Syndrome III: Diagnostic Studies01:30

Acute Coronary Syndrome III: Diagnostic Studies

Diagnosing acute coronary syndrome or ACS begins with a thorough patient history. Notable symptoms include central, crushing chest pain radiating to the left arm, neck, jaw, or back, along with shortness of breath, sweating (diaphoresis), nausea, vomiting, dizziness, and palpitations.It is crucial to note any history of cardiac illnesses and assess risk factors, including age, gender, smoking, hypertension, diabetes, hyperlipidemia, and a sedentary lifestyle.During physical examination, vital...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Acute Coronary Syndrome I: Introduction01:30

Acute Coronary Syndrome I: Introduction

Acute Coronary Syndrome (ACS) encompasses a spectrum of heart conditions caused by sudden obstruction of coronary arteries, typically resulting from the rupture of an atherosclerotic plaque and subsequent thrombus (blood clot) formation. This obstruction can lead to partial or complete blockage of blood flow, causing varying degrees of myocardial ischemia or infarction.ACS includes the following clinical entities:Unstable Angina (UA)Non-ST-Elevation Myocardial Infarction (NSTEMI)ST-Elevation...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Recurrence of Basal Cell Carcinoma across Different Treatment Modalities: A Nationwide Study with 8 Years of Follow-up and Modelled Prediction.

Acta dermato-venereologica·2026
Same author

Cutaneous inflammatory biomarkers in rosacea and their association with disease severity.

Clinical and experimental dermatology·2026
Same author

Clinical characteristics and severity of concomitant atopic dermatitis in adults with asthma: a nationwide population-based registry study.

Frontiers in allergy·2026
Same author

Is There a Golden Hour for Thrombectomy in Intermediate-Risk Pulmonary Embolism? Insights From SYMPHONY-PE.

Circulation. Cardiovascular interventions·2026
Same author

Early-life tonsillectomy and subsequent risk of psoriasis.

Journal of the European Academy of Dermatology and Venereology : JEADV·2026
Same author

Risk of major adverse cardiovascular events in patients with chronic hand eczema from the Danish National Patient Register.

The British journal of dermatology·2026

Related Experiment Video

Updated: May 31, 2026

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
10:03

Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

Published on: January 28, 2020

C-Reactive Protein and Long-Term Risk of Death in Patients with Myocardial Infarction.

Julie Borchsenius, Kristian H Kragholm, Deepak L Bhatt

    Cardiology
    |May 29, 2026
    PubMed
    Summary

    Elevated C-reactive protein (CRP) levels after myocardial infarction predict a higher risk of death and heart failure. This study confirms CRP

    More Related Videos

    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
    04:41

    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

    Published on: July 3, 2018

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
    10:12

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

    Published on: August 8, 2013

    Related Experiment Videos

    Last Updated: May 31, 2026

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty
    10:03

    Coronary Progenitor Cells and Soluble Biomarkers in Cardiovascular Prognosis after Coronary Angioplasty

    Published on: January 28, 2020

    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease
    04:41

    Digital PCR for Quantifying Circulating MicroRNAs in Acute Myocardial Infarction and Cardiovascular Disease

    Published on: July 3, 2018

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay
    10:12

    A Sensitive and Specific Quantitation Method for Determination of Serum Cardiac Myosin Binding Protein-C by Electrochemiluminescence Immunoassay

    Published on: August 8, 2013

    Area of Science:

    • Cardiology
    • Biomarkers
    • Public Health

    Background:

    • The long-term prognostic significance of standard C-reactive protein (CRP) in myocardial infarction (MI) patients remains unclear.
    • Assessing CRP's role in predicting outcomes post-MI is crucial for risk stratification and management.

    Purpose of the Study:

    • To investigate the long-term prognostic value of baseline C-reactive protein (CRP) levels in patients following a first myocardial infarction.
    • To determine the association between CRP quartiles and the risk of all-cause mortality and new-onset heart failure.

    Main Methods:

    • Utilized Danish nationwide registries to identify 29,035 patients diagnosed with myocardial infarction between 2013-2020.
    • Measured C-reactive protein (CRP) levels within 24 hours of hospitalization.
    • Employed multivariable Cox regression with average treatment effect modeling to assess risks for death and heart failure across CRP quartiles, adjusting for key clinical factors.

    Main Results:

    • Higher C-reactive protein (CRP) concentrations were significantly associated with increased risks of death and heart failure.
    • Patients in the highest CRP quartile (>=12 mg/l) exhibited the highest standardized absolute risks for death at both 0-30 and 31-365 days.
    • A stepwise increase in relative risk for death and heart failure was observed with rising CRP levels.

    Conclusions:

    • Elevated C-reactive protein (CRP) levels are a significant independent predictor of long-term mortality and incident heart failure in myocardial infarction survivors.
    • CRP measurement provides valuable prognostic information, aiding in the risk stratification of patients post-myocardial infarction.